ABIE:F:F-AXA IM ACT Biodiversity Equity UCITS ETF EUR(H) Acc (EUR)

ETF | Others |

Last Closing

USD 12.39

Change

+0.10 (+0.81)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.01 (-0.02%)

USD 116.66B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.06 (-0.11%)

USD 91.05B
SXR8:F iShares Core S&P 500 UCITS ETF..

-2.32 (-0.45%)

USD 85.22B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.04 (-0.19%)

USD 74.74B
EUNL:F iShares Core MSCI World UCITS ..

-0.55 (-0.59%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.20%)

USD 55.89B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.03 (-0.20%)

USD 55.84B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.29 (-0.31%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.31 (-0.33%)

USD 51.63B

ETFs Containing ABIE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.86% 52% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.86% 50% F 54% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike